Validation of an HPLC method for the determination of ciprofloxacin in human plasma

Journal of Pharmaceutical and Biomedical Analysis

Volumn 33, Issue 1, 2003, Pages 125-130

  Imre, Silvia ^a   Dogaru, Maria T ^a   Vari, C E ^a   Muntean, T ^b   Kelemen, L ^b  

^a UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b ARMEDICA SA ^*  (Romania)

Author keywords

Ciprofloxacin; Pharmacokinetics; Reversed phase HPLC

Indexed keywords

ACETONITRILE; ANTICOAGULANT AGENT; CIPROFLOXACIN; EDETIC ACID DERIVATIVE; PHOSPHATE; PROTEIN;

ACCURACY; ARTICLE; BIOEQUIVALENCE; CHROMATOGRAPHY; CONTROLLED STUDY; DEVICE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG FORMULATION; DRUG RETENTION; DRUG STABILITY; EXCITATION; FLUOROMETRY; FREEZING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; NORMAL HUMAN; PH; PRECIPITATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TEMPERATURE; THAWING; VALIDATION PROCESS;

ANTI-INFLAMMATORY AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIPROFLOXACIN; FLUOROMETRY; FREEZING; HUMANS; HYDROGEN-ION CONCENTRATION; INDICATORS AND REAGENTS; QUALITY CONTROL; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SPECIMEN HANDLING; THERAPEUTIC EQUIVALENCY;

EID: 0142218315     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(03)00151-1     Document Type: Article

References (19)

1. Physician's Desk Reference, Medical Economics Company, Inc at Montvale, NJ, USA, 2001, sec. 5, p. 848.
2. Ba B.B., Ducint D., Fourthillan M., Saux M.C. J. Chromatogr. B. 714:1998;317-324.
3. Jehl F., Gallon C., Debs J., Brogard J.M., Monteil H., Minck R. J. Chromatogr. 339:1985;347-357.
4. Awni W.M., Clarkson J., Guay D.R.P. J. Chromatogr. 419:1987;414-420.
5. Pei Y.Y., Meng X., Nightingale C.H. Acta Pharmacol. Sinica. 15:1994;197-201.
6. Kamberi M., Hajime N., Kamberi P., Uemura N., Nakamura K., Nakano S. Ther. Drug Monit. 21:(3):1999;335-340.
7. Morley J.A., Elrod L. Chromatographia. 37:(5/6):1993;295-299.
8. El-Yazigi A., Al-Rawithy S. Ther. Drug Monit. 12:(4):1990;378-381.
9. Weber A., Chaffin D., Smith A., Opheim K.E. Antimicrob. Agents Chemother. 27:(4):1985;531-534.
10. Morton S.J., Shull V.H., Dick J.D. Antimicrob. Agents Chemother. 30:(2):1986;325-327.
11. Meyers C.M., Blumer J.L. J. Chromatogr. 422:1987;153-164.
12. Mack G. J. Chromatogr. 582:1992;263-267.
13. Zotou A., Miltiadou N. J. Pharm. Biomed. Anal. 28:(3-4):2002;559-568.
14. Nix D.E., De Vito J.M., Schentag J.J. Clin. Chem. 31:1985;684-686.
15. Maya M.T., Goncalves N.J., Silva N.B., Morais J.A. J. Chromatogr. B. 755:(1-2):2001;305-309.
16. Krol G.J., Beck G.W., Benham T. J. Pharm. Biomed. Anal. 14:1995;181-190.
17. OECD Principles of Good Laboratory Practice (as revised in 1997).
18. US Department of Health and Human Services, Food and Drug Administration, Guidance for Industry - Bioanalytical Method Validation, May 2001.
19. The European Agency for the Evaluation of Medicinal Products, Note for Guidance on the Investigation of Bioavailability and Bioequivalence, 26 July 2001.